Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Surgery Partners Inc’s stock clocked out at $30.11, down -3.37% from its previous closing price of $31.16. In other words, the price has decreased by -$3.37 from its previous closing price. On the day, 0.66 million shares were traded. SGRY stock price reached its highest trading level at $31.04 during the session, while it also had its lowest trading level at $30.07.
Ratios:
To gain a deeper understanding of SGRY’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 17.93 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.75. For the most recent quarter (mrq), Quick Ratio is recorded 1.69 and its Current Ratio is at 1.83. In the meantime, Its Debt-to-Equity ratio is 1.76 whereas as Long-Term Debt/Eq ratio is at 1.69.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Macquarie on June 28, 2024, initiated with a Outperform rating and assigned the stock a target price of $31.
On March 06, 2024, Barclays started tracking the stock assigning a Equal Weight rating and target price of $35.
TD Cowen Upgraded its Market Perform to Outperform on November 14, 2023, whereas the target price for the stock was revised from $39 to $35.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 05 ’24 when Bradley Owens bought 9,241 shares for $30.69 per share.
Bane Harrison R. sold 6,325 shares of SGRY for $196,742 on Sep 04 ’24. The National Group President now owns 48,236 shares after completing the transaction at $31.11 per share. On Sep 04 ’24, another insider, Harrison Bane, who serves as the Officer of the company, bought 6,325 shares for $31.11 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGRY now has a Market Capitalization of 3827703808 and an Enterprise Value of 8661096448. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.32 while its Price-to-Book (P/B) ratio in mrq is 1.96. Its current Enterprise Value per Revenue stands at 2.998 whereas that against EBITDA is 15.047.
Stock Price History:
The Beta on a monthly basis for SGRY is 2.76, which has changed by 0.10653412 over the last 52 weeks, in comparison to a change of 0.3069358 over the same period for the S&P500. Over the past 52 weeks, SGRY has reached a high of $36.92, while it has fallen to a 52-week low of $22.05. The 50-Day Moving Average of the stock is -2.33%, while the 200-Day Moving Average is calculated to be 3.82%.
Shares Statistics:
It appears that SGRY traded 1.02M shares on average per day over the past three months and 598970 shares per day over the past ten days. A total of 126.59M shares are outstanding, with a floating share count of 70.88M. Insiders hold about 44.25% of the company’s shares, while institutions hold 68.84% stake in the company. Shares short for SGRY as of 1726185600 were 9984935 with a Short Ratio of 9.77, compared to 1723680000 on 11316981. Therefore, it implies a Short% of Shares Outstanding of 9984935 and a Short% of Float of 17.29.
